AMENDMENT NO. 1 TO LICENSE AGREEMENT dated as of September 18, 2006 between PONIARD PHARMACEUTICALS, INC. and ANORMED INC.License Agreement • November 14th, 2006 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
THIS AMENDMENT NO. 1 TO LICENSE AGREEMENT (this “Amendment”), effective as of September 18, 2006 (the “Amendment Date”), is entered into between ANORMED INC. (“AnorMED”), a corporation organized and existing under the laws of Canada and having an office at #200 – 20353 64th Ave, Langley, BC Canada V2Y 1N5, and PONIARD PHARMACEUTICALS, INC. (“Poniard”), a corporation organized and existing under the laws of the State of Washington and having an office at 300 Elliott Avenue West, Suite 500, Seattle, WA 98119, with respect to the following facts:
